Enzyme-replacement therapy in mucopolysaccharidosis I

Article Abstract:

Enzyme replacement therapy may be beneficial for patients with mucopolysaccharidosis I, according to a study of 10 patients. This disease is caused by a deficiency of the enzyme alpha-L-iduronidase. This leads to the accumulation of metabolic byproducts that can damage the liver, heart, joints, and other organs.

Health aspects, Enzymes, Enzyme therapy

---

Advances in the treatment of mucopolysaccharidosis type 1

Article Abstract:

Mucopolysaccharidoses are a group of lysosomal storage diseases caused by a deficiency of enzymes that degrade glycosaminoglycans. Characteristics and treatment of this severe disease is discussed.

Development and progression, Connective tissue diseases

---

Pluripotency redux - advances in stem-cell research

Article Abstract:

The article states pluripotency as one of the major advances in stem-cell research, which will be of use for reprogramming of adult human cells to produce patient-specific therapies.

Science & research, Research, Human cell culture, Stem cell research

Similar abstracts:

• Abstracts: Evidence-based practice in pressure sore reduction. Improving policy and practice in the prevention of pressure ulcers
• Abstracts: Evaluating a new care planning system in nursing homes. Reducing the incidence of falls and hip fractures in care homes
• Abstracts: Growth hormone therapy in adults. Hemochromatosis: Genetics and pathophysiology
• Abstracts: "Failure to thrive" in older adults. A broader role for advance medical planning. Cost-effective management of flu in adults older than 65 years of age
• Abstracts: Transient acute depression induced by high-frequency deep-brain stimulation. Costs to society of family caregiving for patients with end-stage Alzheimer's disease

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.